Tech Company Financing Transactions
Sitari Pharmaceuticals Funding Round
On 11/23/2013, Sitari Pharmaceuticals raised $10 million in Series A investment from Avalon Ventures and GlaxoSmithKline.
Transaction Overview
Company Name
Announced On
11/23/2013
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Avalon Ventures (Jay Lichter)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Diego, CA 94105
USA
San Diego, CA 94105
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Sitari Pharmaceuticals a biotech startup was founded by Avalon with intellectual property from Stanford University.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Lichter
Chief Financial Officer
Douglas Downs
Chief Scientific Officer
David Campbell
Browse more venture capital transactions:
Prev: 11/23/2013: Coursera venture capital transaction
Next: 11/24/2013: Veenome venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to document every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs